UK markets close in 6 hours 40 minutes

NICE Ltd. (NICE.TA)

Tel Aviv - Tel Aviv Delayed price. Currency in ILA (0.01 ILS)
Add to watchlist
70,460.00-470.00 (-0.66%)
As of 11:34AM IDT. Market open.
Currency in ILA

Valuation measures4

Market cap (intra-day) 45.01B
Enterprise value 41.58B
Trailing P/E 32.74
Forward P/E 17.12
PEG ratio (5-yr expected) 1.43
Price/sales (ttm)4.89
Price/book (mrq)3.35
Enterprise value/revenue 4.31
Enterprise value/EBITDA 15.93

Trading information

Stock price history

Beta (5Y monthly) 0.41
52-week change 3-5.50%
S&P500 52-week change 326.94%
52-week high 398,410.00
52-week low 360,390.00
50-day moving average 385,468.20
200-day moving average 376,390.45

Share statistics

Avg vol (3-month) 381.8k
Avg vol (10-day) 3120.31k
Shares outstanding 563.46M
Implied shares outstanding 663.46M
Float 862.94M
% held by insiders 10.00%
% held by institutions 112.07%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 427 Feb 2017
Last split factor 22:1
Last split date 331 May 2006

Financial highlights

Currency in USD.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 14.92%
Operating margin (ttm)18.42%

Management effectiveness

Return on assets (ttm)5.71%
Return on equity (ttm)11.16%

Income statement

Revenue (ttm)2.46B
Revenue per share (ttm)38.87
Quarterly revenue growth (yoy)15.30%
Gross profit (ttm)N/A
EBITDA 636.16M
Net income avi to common (ttm)367.73M
Diluted EPS (ttm)21.63
Quarterly earnings growth (yoy)38.30%

Balance sheet

Total cash (mrq)1.5B
Total cash per share (mrq)23.75
Total debt (mrq)570.65M
Total debt/equity (mrq)16.50%
Current ratio (mrq)2.43
Book value per share (mrq)54.47

Cash flow statement

Operating cash flow (ttm)620.85M
Levered free cash flow (ttm)637.32M